Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPCG17: Prostate Cancer Active Surveillance Trigger Trial (PCASTT)

NCT02914873 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT02914873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02914873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPCG17: Prostate Cancer Active Surveillance Trigger Trial (PCASTT)
Lead sponsor
Uppsala University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 3, 2016
Completion date
December 31, 2034
Enrollment
2,008 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer